feed,title,long_url,short_url
Benzinga,Sarepta's Stock Trading Higher As Duchenne Muscular Dystrophy Gene Therapy Shows Promise In Open-Label Study,https://benzinga.com/general/biotech/21/05/21177614/sareptas-stock-trading-higher-as-duchenne-muscular-dystrophy-gene-therapy-shows-promise-in-open-l,https://j.mp/3wfVH7o
